大庆华科(000985) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥629,173,594.69, an increase of 2.02% compared to ¥616,709,642.53 in the same period last year[3] - Net profit attributable to shareholders decreased by 82.47% to ¥2,273,226.83 from ¥12,964,510.88 year-on-year[3] - The net profit after deducting non-recurring gains and losses fell by 86.83% to ¥1,623,668.20 from ¥12,329,026.83 in the previous year[3] - Basic and diluted earnings per share both decreased by 82.00% to ¥0.018 from ¥0.100 year-on-year[3] - The operating profit for Q1 2023 was CNY 2,621,587.62, down 82.8% from CNY 15,227,874.59 in Q1 2022[15] - The total comprehensive income for Q1 2023 was CNY 2,273,226.83, significantly lower than CNY 12,964,510.88 in Q1 2022[15] Cash Flow and Liquidity - Cash flow from operating activities improved significantly, reaching ¥23,254,404.49, compared to a negative cash flow of ¥5,052,681.00 in the same period last year, representing a 560.24% increase[3] - The cash and cash equivalents at the end of Q1 2023 amounted to CNY 248,525,268.02, compared to CNY 228,687,496.92 at the beginning of the year, indicating a growth of 8.3%[11] - The cash and cash equivalents at the end of Q1 2023 amounted to CNY 248,525,268.02, slightly down from CNY 250,194,369.72 at the end of Q1 2022[18] - The net cash flow from investing activities was CNY -3,416,633.39, compared to CNY -2,905,940.56 in Q1 2022[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥723,240,713.05, an increase of 2.43% from ¥706,073,765.92 at the end of the previous year[3] - Total assets as of the end of Q1 2023 were CNY 723,240,713.05, an increase from CNY 706,073,765.92 at the beginning of the year[14] - Total liabilities increased to CNY 117,990,522.50 from CNY 102,903,123.88, representing a rise of 14.7%[13] Shareholder Information - The total number of common shareholders at the end of the reporting period was 10,031[6] - The largest shareholder, China Petroleum Daqing Petrochemical Co., Ltd., holds 55.03% of the shares[6] - Shareholders' equity attributable to shareholders increased slightly by 0.34% to ¥605,250,190.55 from ¥603,170,642.04 at the end of the previous year[3] Operational Metrics - Total operating costs for Q1 2023 were CNY 622,783,990.80, up from CNY 601,545,404.03, reflecting a year-over-year increase of 3.7%[14] - Gross profit margin for Q1 2023 was approximately 1.6%, down from the previous year's margin[14] - Inventory at the end of Q1 2023 was CNY 140,404,795.13, up from CNY 126,991,745.34, reflecting an increase of 10.5%[12] - The company reported a decrease in accounts payable from CNY 26,368,633.96 to CNY 22,952,222.23, a reduction of 13.5%[13] Government Support and R&D - The company received government subsidies amounting to ¥711,392.82, with a net impact of ¥649,558.63 after tax considerations[5] - The company plans to continue focusing on research and development, with R&D expenses for Q1 2023 amounting to CNY 3,427,151.44, slightly down from CNY 3,677,702.08 in the previous year[14] Other Information - The company did not report any significant new product developments or market expansions during this quarter[15] - The company reported an asset impairment loss of CNY -4,571,967.06, compared to CNY -762,649.72 in the previous year[15] - Sales revenue from goods and services received cash of CNY 716,067,889.76, an increase from CNY 701,519,167.69 in the same period last year[17]